APA (7th ed.) Citation

AM, B., M, C., WC, J., BT, C., AN, A., MB, A., . . . SP, C. (2022). Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy. Frontiers in oncology, 11, 794615. https://doi.org/10.3389/fonc.2021.794615

Chicago Style (17th ed.) Citation

AM, Burke, Carrasquilla M, Jean WC, Collins BT, Anaizi AN, Atkins MB, Gibney GT, and Collins SP. "Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy." Frontiers in Oncology 11 (2022): 794615. https://doi.org/10.3389/fonc.2021.794615.

MLA (9th ed.) Citation

AM, Burke, et al. "Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy." Frontiers in Oncology, vol. 11, 2022, p. 794615, https://doi.org/10.3389/fonc.2021.794615.